secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001854270-24-000041
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences appoints Yvonne Li Interim CFO; CEO Lu named interim PFO
--------------------------------------------------------------------------

- Timothy Lu, CEO/President, becomes interim principal financial & accounting officer effective May 4, 2024.
- Yvonne Li appointed Interim CFO effective May 4, 2024; will become principal financial & accounting officer after Q1 10-Q filing.
- Li consulting agreement: $350/hour, max aggregate payment of $370,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000041/0001854270-24-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000041/snti-20240426.htm
  HTML page:      https://secwatch.observer/filing/0001854270-24-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer